Overview

Safety and Efficacy of Methylene Blue Combined With Artesunate or Amodiaquine for Malaria Treatment in Children of Burkina Faso: a Pilot Study

Status:
Completed

Trial end date:
2006-11-01

Target enrollment:

Participant gender:

Summary

The primary objective of this trial is to study the safety of the combination methylene blue (MB)-artesunate (AS) and MB-amodiaquine (AQ) in treating malaria among children compared to the safety of an AS-AQ regimen. The secondary objective is to investigate the efficacy of MB-AS and MB-AQ.

Phase:

Phase 2

Details

Lead Sponsor:

Heidelberg University

Treatments:

Amodiaquine
Artemisinins
Artesunate
Methylene Blue